The technology behind COVID jabs
The World Health Organization on Tuesday authorised its 10th COVID-19 vaccine—Nuvaxovid from US firm Novavax.
Dec 21, 2021
0
7
The World Health Organization on Tuesday authorised its 10th COVID-19 vaccine—Nuvaxovid from US firm Novavax.
Dec 21, 2021
0
7
Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn't appear strong enough for some of the children.
Dec 17, 2021
0
11
The EU's drug regulator on Thursday allowed member states to use Pfizer's new COVID pill ahead of its formal approval, as an emergency measure to curb an Omicron-fuelled wave.
Dec 16, 2021
0
7
The omicron variant is offering more hints about what it may have in store as it spreads around the globe: A highly transmissible virus that may cause less severe disease, and one that can be slowed—but not stopped—by ...
Dec 14, 2021
0
28
(HealthDay)—Compared to previous coronavirus variants, Omicron appears to cause less severe illness, but is more resistant to the Pfizer vaccine, researchers at South Africa's largest health insurer report.
Dec 14, 2021
0
1
Pfizer said Tuesday that clinical trials confirmed its COVID pill—a new type of treatment that should withstand the mutations seen with the Omicron variant—drastically reduced hospitalizations and deaths among at-risk ...
Dec 14, 2021
0
11
(HealthDay)—Booster doses of Pfizer's coronavirus vaccine set recipients up to effectively withstand the ravages of both the Delta and Omicron variants, a group of new studies suggest.
Dec 9, 2021
0
6
U.S. health authorities again expanded the nation's booster campaign Thursday, opening extra doses of Pfizer's COVID-19 vaccine to several million 16- and 17-year-olds.
Dec 9, 2021
0
1
Two doses of the BioNTech and Pfizer coronavirus vaccine may not be enough to protect against the Omicron strain, the companies warned Wednesday, but they stressed it was "still effective" after a third jab.
Dec 8, 2021
0
2
(HealthDay)—Pfizer Inc. is expected to seek approval this week for emergency use of its booster shots among American teens ages 16-17.
Nov 30, 2021
0
3